Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals

  Biotechnology Law Report
  Volume 24, Number 2, April 2005
  homepage                   other issues

  • Papers
  • Health Care Business Method Patents: Prior Art, Secrecy, and Secondary Indicia of Obviousness
        Melissa R. Leuenberger-Fisher
        p.149-167                                                                              +cite        
  • Employees' Invention Remuneration - Money (f)or Nothing?
        Jürgen Meier, Thure Schubert, Hans-Rainer Jaenichen
        p.168-175                                                                              +cite        

  • Brief Comment on Recent Developments
  • Inequitable Conduct for Failure to Cite to PTO Material Information Turned Over to the FDA
        Harold C. Wegner
        p.176-176                                                                              +cite        

  • Regulatory Affairs Pharmaceutical
  • FDA Orders New Phase III Trial for Anticancer Drug; SuperGen Withdraws Orathecin NDA; FDA Okays Keratinocyte Growth Factor for Prevention of Mucositis During Chemotherapy; AstraZeneca Withdraws Application for European Approval of Iressa; FDA Approves Anti-Angiogenesis Agent for "Wet" Age-Related Macular Degeneration; Access Pharmaceuticals Gets Clearance for Clinical Trials of AP5346; FDA Establishes Nanotechnology Site; Microarray Chip for Genetic Analysis Receives FDA Clearance
        p.177-179                                                                              +cite    

  • Clinical Trials
  • Pfizer Halts Trial of Drug for Gastrointestinal Stromal Tumors Because Efficacy Endpoint Has Been Met; StemCells Applies for Clinical Trial of Stem Cells; Clinical Trial Approval Granted for Candidate Alzheimer's Drug; Another Trial of RNA Silencing to Begin at City of Hope
        p.180-181                                                                              +cite    

  • Regulatory Affairs - Agricultural and Environmental
  • Mexico Approves Procedures for Planting Genetically Modified Corn; UN's FAO Wants Tight Controls on Agricultural Biotechnology; APHIS Deregulates Herbicide-Resistant Cotton Variety; New Developments in European Regulation of Genetically Modified Crops
        p.182-184                                                                              +cite    

  • Patents
  • Germany Enacts a Biotechnology Patent Law; AVI BioPharm Receives Stem Cell Antisense Technology Patent and Allowance; Third Amendment to Indian Patent Law Takes Effect; U.S., Israel in Dispute over Patent Law on Drugs
        p.185-186                                                                              +cite    

  • Patent Litigation
  • Certiorari Granted in Merck v. Integra; Denial of Promoter Patent Upheld by CAFC; Geron Wins Interference Proceeding on Nuclear Transfer Technology; Syngenta to Appeal Patent Verdict; Monsanto, Bayer CropScience Arrange Cross Licenses; "Star Fruits Must Await a Rejection ... and Then Litigate the Propriety of That Rejection"; What Constitutes Litigation Misconduct and Vexatious Behavior?; The Meaning of "About"
        p.187-197                                                                              +cite    

  • Licensing and Collaborations
  • Royalty Award Against Genentech Overturned
        p.198-198                                                                              +cite    

  • Financial and Shareholder Affairs
  • Cambridge Antibody Technology Wins More Royalties from Abbott; Australian Stock Exchange Cracking Down on Biotechnology Company Announcements; NIH Releases New Ethics Rules
        p.199-200                                                                              +cite    

  • Science and Society
  • NIH Releases Public Access Policy; Penn, National Medical Center Settle over Gene Therapy Trial
        p.201-201                                                                              +cite    
  • Bibliography
        p.202-202                                                                              +cite    
  • On the Move
        p.203-206                                                                              +cite    

  • Texts
  • Bruno Independent Living Aids, Inc. v. Acorn Mobility Services, Ltd.
        p.207-212                                                                              +cite    
  • In re James F. Crish and Richard L. Eckert
        p.213-218                                                                              +cite    
  • Star Fruits S.N.C. et al. v. U.S. and Department of Commerce et al.
        p.219-226                                                                              +cite    
  • Matthew Stephens and Spectrum Laboratories, Inc. v. Tech International, Inc. et al.
        p.227-232                                                                              +cite    
  • Merck & Co., Inc. v. Teva Pharmaceuticals USA, Inc.
        p.233-246                                                                              +cite    
  • Petition for Review of City of Hope Nat'l Med. Ctr. v. Genentech, Inc.
        p.247-251                                                                              +cite    
  • Coming Events
        p.252-255                                                                              +cite